Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Animal models of antiretroviral prophylaxis for HIV prevention.

García-Lerma JG, Heneine W.

Curr Opin HIV AIDS. 2012 Nov;7(6):505-13. doi: 10.1097/COH.0b013e328358e484. Review.

PMID:
22964889
2.

Nondaily preexposure prophylaxis for HIV prevention.

Anderson PL, García-Lerma JG, Heneine W.

Curr Opin HIV AIDS. 2016 Jan;11(1):94-101. doi: 10.1097/COH.0000000000000213. Review.

3.

Considerations regarding antiretroviral chemoprophylaxis in MSM.

Poynten IM, Zablotska I, Grulich AE.

Curr Opin HIV AIDS. 2012 Nov;7(6):549-56. doi: 10.1097/COH.0b013e3283582c71. Review.

PMID:
22918448
4.

Oral pre-exposure prophylaxis for HIV prevention.

García-Lerma JG, Paxton L, Kilmarx PH, Heneine W.

Trends Pharmacol Sci. 2010 Feb;31(2):74-81. doi: 10.1016/j.tips.2009.10.009. Epub 2009 Dec 4. Review.

PMID:
19963288
5.

Should we fear resistance from tenofovir/emtricitabine preexposure prophylaxis?

Parikh UM, Mellors JW.

Curr Opin HIV AIDS. 2016 Jan;11(1):49-55. doi: 10.1097/COH.0000000000000209. Review.

6.

Oral antiretroviral chemoprophylaxis: current status.

Baeten J, Celum C.

Curr Opin HIV AIDS. 2012 Nov;7(6):514-9. doi: 10.1097/COH.0b013e3283582d30. Review.

7.

The clinical pharmacology of antiretrovirals for HIV prevention.

Hendrix CW.

Curr Opin HIV AIDS. 2012 Nov;7(6):498-504. doi: 10.1097/COH.0b013e32835847ae. Review.

PMID:
22964888
8.

Systemic and topical drugs for the prevention of HIV infection: antiretroviral pre-exposure prophylaxis.

Baeten J, Celum C.

Annu Rev Med. 2013;64:219-32. doi: 10.1146/annurev-med-050911-163701. Epub 2012 Sep 27. Review.

9.

Cost-effectiveness of pre-exposure prophylaxis for HIV: a review.

Schackman BR, Eggman AA.

Curr Opin HIV AIDS. 2012 Nov;7(6):587-92. doi: 10.1097/COH.0b013e3283582c8b. Review.

PMID:
23076124
10.

Next-generation oral preexposure prophylaxis: beyond tenofovir.

Abraham BK, Gulick R.

Curr Opin HIV AIDS. 2012 Nov;7(6):600-6. doi: 10.1097/COH.0b013e328358b9ce. Review.

11.

The risk of HIV drug resistance following implementation of pre-exposure prophylaxis.

van de Vijver DA, Boucher CA.

Curr Opin Infect Dis. 2010 Dec;23(6):621-7. doi: 10.1097/QCO.0b013e32833ff1e6. Review.

PMID:
20847692
12.

The promise of pre-exposure prophylaxis with antiretroviral drugs to prevent HIV transmission: a review.

Hankins CA, Dybul MR.

Curr Opin HIV AIDS. 2013 Jan;8(1):50-8. doi: 10.1097/COH.0b013e32835b809d. Review.

PMID:
23201856
13.

HIV prevention by oral preexposure prophylaxis.

Heneine W, Kashuba A.

Cold Spring Harb Perspect Med. 2012 Mar;2(3):a007419. doi: 10.1101/cshperspect.a007419. Review.

14.

Pre-exposure prophylaxis (PrEP) in HIV-uninfected individuals with high-risk behaviour.

Nadery S, Geerlings SE.

Neth J Med. 2013 Jul-Aug;71(6):295-9. Review.

15.

Assessment of topical microbicides to prevent HIV-1 transmission: concepts, testing, lessons learned.

Friend DR, Kiser PF.

Antiviral Res. 2013 Sep;99(3):391-400. doi: 10.1016/j.antiviral.2013.06.021. Epub 2013 Jul 8. Review.

PMID:
23845918
16.

Cabotegravir long-acting for HIV-1 prevention.

Andrews CD, Heneine W.

Curr Opin HIV AIDS. 2015 Jul;10(4):258-63. doi: 10.1097/COH.0000000000000161. Review.

PMID:
26049951
17.

Evaluation of antiretrovirals in animal models of HIV infection.

Van Rompay KK.

Antiviral Res. 2010 Jan;85(1):159-75. doi: 10.1016/j.antiviral.2009.07.008. Epub 2009 Jul 19. Review.

PMID:
19622373
18.

Antiretroviral-based HIV-1 prevention: antiretroviral treatment and pre-exposure prophylaxis.

Celum C, Baeten JM.

Antivir Ther. 2012;17(8):1483-93. doi: 10.3851/IMP2492. Epub 2012 Dec 7. Review.

19.

[Pre-exposure prophylaxis for the prevention of sexual HIV transmission; new preventative strategy using tenofovir/emtricitabine].

Boot J, Rump BO, Boucher CA, Op de Coul EL, van Agtmael MA, van de Vijver DA, Burger DM, Fanoy EB.

Ned Tijdschr Geneeskd. 2013;157(27):A6063. Review. Dutch.

PMID:
23838402
20.

Systemic preexposure prophylaxis for human immunodeficiency virus infection.

Romanelli F, Murphy B.

Pharmacotherapy. 2010 Oct;30(10):1021-30. doi: 10.1592/phco.30.10.1021. Review.

PMID:
20874040

Supplemental Content

Support Center